Research has indicated that CRT expression on the surface of acute myeloid leukemia cells stimulates the secretion of type I IFN by the CD8 + αDC subpopulation, which is necessary for T cell activation and induction of the immune response involved in tumor rejection [38]. This evidence concerns the gene CD8A and neoplasm.